The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_004700.3(KCNQ4):c.825G>C (p.Trp275Cys)

CA21112664

505302 (ClinVar)

Gene: KCNQ4
Condition: nonsyndromic genetic deafness
Inheritance Mode: Autosomal dominant inheritance
UUID: 3e8e4973-8620-4a94-8c71-3bdec36a8281

HGVS expressions

NM_004700.3:c.825G>C
NM_004700.3(KCNQ4):c.825G>C (p.Trp275Cys)
NC_000001.11:g.40819463G>C
CM000663.2:g.40819463G>C
NC_000001.10:g.41285135G>C
CM000663.1:g.41285135G>C
NC_000001.9:g.41057722G>C
NG_008139.1:g.40452G>C
NG_008139.2:g.40452G>C
NM_172163.2:c.825G>C
NM_004700.4:c.825G>C
ENST00000347132.9:c.825G>C
ENST00000443478.3:n.511G>C
ENST00000506017.1:n.144G>C
ENST00000509682.6:n.825G>C

Likely Pathogenic

Met criteria codes 4
PP3 PM5 PM1 PM2
Not Met criteria codes 19
PP1 PP4 PM3 PM4 PM6 PVS1 BA1 BS1 BS4 BS2 BP5 BP7 BP4 BP2 BP3 PS4 PS3 PS2 PS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Hearing Loss VCEP
The c.825G>C (p.Trp275Cys) variant was found in one patient with hearing loss (PS4 not met; Partners LMM ClinVar SCV000712456.1). The p.Trp275Cys variant in the KCNQ4 gene was absent from the Genome Aggregation Database (http://gnomad.broadinstitute.org) (PM2). A different pathogenic missense variant (p.Trp275Arg) and a likely pathogenic missense variant (p.Trp275Ser) have been previously identified at this codon of KCNQ4 which may indicate that this residue is critical to the function of the protein (PM5; ClinVar Variation ID 6242, PMID: 25116015, 20301388; ClinVar Variation ID 372951). Furthermore, the variant is in a location that has been defined by the ClinGen Hearing Loss Expert Panel to be a mutational hotspot or domain of KCNQ4 (PM1; PMID: 23717403 https://www.uniprot.org/uniprot/P56696). Computational prediction tools and conservation analysis suggest that the p.Trp275Cys variant may impact the protein (PP3). In summary, this variant meets criteria to be classified as likely pathogenic for autosomal dominant non-syndromic hearing loss based on the ACMG/AMP criteria applied as specified by the Hearing Loss Expert Panel: (PM2, PM5, PM1, PP3).
Met criteria codes
PP3
REVEL score of 0.928
PM5
NM_004700.3(KCNQ4):c.823T>C (p.Trp275Arg) is classified as Path by the ClinVar staff PMID: 25116015 (segregated with HL in 11 family members), 20301388 NM_004700.3(KCNQ4):c.824G>C (p.Trp275Ser) is classified as LP by GeneDx. Also, c.827G>C (p.Trp276Ser) variant has been reported in ClinVar as Pathogenic by the LMM, OMIM, and GeneReviews.
PM1
The variant occurs in the KCNQ4 hot spot: between amino acids 271-292.
PM2
Absent from gnomAD
Not Met criteria codes
PP1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM6
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PVS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BA1
Absent from gnomAD
BS1
Absent from gnomAD
BS4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP7
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP4
REVEL score of 0.928
BP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Approved on: 2018-09-10
Published on: 2019-07-17
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.